Mysoline (Primidone)

Primidone, the active ingredient in Mysoline, is an anticonvulsant presented as an oral tablet for oral use. It is employed to control seizures in patients with epilepsy and to reduce tremor intensity in individuals with essential tremor.

GNH USA supplies Mysoline as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Primidone is used in the management of seizure disorders and movement disorders by modulating neuronal excitability. - Epilepsy: Reduces frequency and severity of generalized and partial seizures. - Essential tremor: Diminishes tremor amplitude, improving motor control. - Seizure disorders: Provides broad seizure control for patients not adequately managed by other antiepileptics.

Primidone may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: Feeling of sleepiness or reduced alertness. - Dizziness: Light‑headed sensation, especially when standing quickly. - Nausea: Stomach upset that may lead to vomiting. - Fatigue: Generalized lack of energy and motivation.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Blood dyscrasias: Agranulocytosis, leukopenia, or thrombocytopenia. - Hepatic dysfunction: Elevated liver enzymes or hepatitis.

When prescribing Primidone, clinicians should consider several safety measures to minimize risks. - Pregnancy: Safety in pregnancy is unknown; use only if potential benefit justifies risk. - Hepatic impairment: Use caution and consider dose reduction in patients with liver disease. - Renal impairment: Adjust dosage in severe renal dysfunction. - Blood monitoring: Periodically assess complete blood count for hematologic abnormalities. - Discontinuation: Do not stop abruptly; taper gradually to avoid withdrawal seizures. - Store at below 25°C: Keep in original packaging, protect from moisture and heat.

Primidone can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Phenobarbital: Additive central nervous system depression may increase sedation. - Alcohol: Concurrent use can enhance drowsiness and impair coordination. - Carbamazepine: Enzyme induction may reduce Primidone plasma levels, decreasing effectiveness.

Moderate Interactions (Monitor Closely): - Oral contraceptives: Primidone may lower hormonal efficacy, increasing risk of breakthrough bleeding. - Warfarin: May alter INR values, requiring closer anticoagulation monitoring. - Phenytoin: Enzyme induction can affect Primidone metabolism, necessitating dose adjustments.